Clinical trial
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
NCT00465192 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00465192 |
|---|---|
| Title | Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Comparing the Efficacy and Safety of 17-Beta Estradiol 10 Micrograms and 25 Micrograms (Vagifem) Doses in Treatment of Estrogen Deficiency-Derived Atrophic Vaginitis |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Postmenopausal Vaginal Atrophy |
| Intervention type | Drug |
| Interventions | estradiol, 10 mcg, 25 mcg, placebo |
| Enrollment | 230 |
| Start date | Aug 31, 1994 |
| Primary completion | Nov 30, 1995 |
| Completion | Nov 30, 1995 |
| First posted | Apr 24, 2007 |
| Last update posted | Mar 1, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: